Tetrabenazine

DRUG4 trials

Sponsors

Centre for Addiction and Mental Health, Joseph Jankovic, Centre Hospitalier Universitaire, Amiens, William Ondo, MD

Conditions

Huntington's DiseaseHyperkinetic Movement DisordersSchizoaffective DisorderSchizophreniaTardive Dyskinesia

Phase 3

Xenazine in Late Dyskinetic Syndrome With Neuroleptics

CompletedNCT01543321

Centre Hospitalier Universitaire, AmiensTardive Dyskinesia

Start: 2012-05-14End: 2017-08-31Updated: 2025-11-19

Phase 4

A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)

William Ondo, MDHuntington's Disease

Start: 2018-08-01End: 2023-07-01Target: 20Updated: 2022-09-02

Unknown Phase

Tetrabenazine for Partial Responders

CompletedNCT00362804

Centre for Addiction and Mental HealthSchizoaffective Disorder, Schizophrenia

Start: 2002-02-28End: 2006-01-31Updated: 2012-07-06

Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements

Joseph JankovicHyperkinetic Movement Disorders

Updated: 2023-03-24

Related Papers

Huntington’s Disease Clinical Trials Corner: August 2018

Journal of Huntington s Disease2018-06-0131 citations

Huntington’s Disease Clinical Trials Corner: February 2018

2018-01-0144 citations